RecruitingNot ApplicableNCT06727695

Effect of BioStrength Training on Muscle Strength and Satisfaction in Adults Aged 30-65

A Comparative Study of Training Effectiveness: Technogyms Biostrength Devices Vs. Conventional Strength Training Devices: a Randomized Controlled Trial


Sponsor

University of Graz

Enrollment

42 participants

Start Date

Oct 8, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the effectiveness of Technogyms BioStrength equipment compared to traditional strength training equipment over a 12-week intervention period. The study will determine whether BioStrength machines produce more effective results in terms of muscle strength and body composition. Participants will be allocated to either the BioStrength group or the traditional training group using a minimisation technique to balance important prognostic factors such as handgrip strength, age and gender between the groups. Key measurements include maximum strength tests (10RM) for leg press and chest press, handgrip strength using a dynamometer, and body composition using bioimpedance analysis. Circumference measurements will also be taken. The study will assess whether BioStrength equipment provides superior results in muscle strength, body composition and training efficiency compared to conventional gym equipment.


Eligibility

Min Age: 30 YearsMax Age: 65 Years

Inclusion Criteria6

  • • Age between 30 and 65 years
  • Healthy individuals without significant medical conditions
  • Less than 6 months of prior strength training experience
  • Willing and able to participate in a 12-week training program
  • Capable of performing strength training exercises such as leg press and chest press
  • Able to provide written informed consent

Exclusion Criteria8

  • • History of coronary heart disease
  • History of stroke
  • Need for changes in antihypertensive treatment within 3 months prior to study start
  • Arthritis
  • Pregnancy or less than three months postpartum
  • Pain and movement restrictions
  • Use of medications that affect muscle strength or performance (e.g., anabolic steroids, beta-2 agonists, glucocorticoids, statins, benzodiazepines, ACE inhibitors, angiotensin-II receptor blockers, diuretics)
  • Any medical condition preventing participation in planned endurance and strength training

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBioStrength Intervention

Participants in the Intervention Group will undergo BioStrength training using Technogym equipment. The intervention will last for 12 weeks, with sessions conducted 3 times per week

DEVICEConventional training

Participants in the Active Comparator group will undergo a conventional strength training program using standard gym machines. Training sessions will occur 3 times per week for 12 weeks. The goal is to compare the outcomes of BioStrength training with traditional strength training.


Locations(1)

CF Leibnitz

Leibnitz, Styria, Styria, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06727695


Related Trials